Hal Atkinson to Risk Factors
This is a "connection" page, showing publications Hal Atkinson has written about Risk Factors.
Connection Strength
0.248
-
Dharod A, Wells BJ, Lenoir K, Willeford WG, Milks MW, Atkinson HH. Holiday Discharges Are Associated with Higher 30-Day General Internal Medicine Hospital Readmissions at an Academic Medical Center. South Med J. 2019 06; 112(6):338-343.
Score: 0.101
-
Stone AV, Jinnah A, Wells BJ, Atkinson H, Miller AN, Futrell WM, Lenoir K, Emory CL. Nutritional markers may identify patients with greater risk of re-admission after geriatric hip fractures. Int Orthop. 2018 02; 42(2):231-238.
Score: 0.022
-
Burns CA, Lambros MA, Atkinson HH, Russell G, Fitch MT. Preclinical medical student observations associated with later professionalism concerns. Med Teach. 2017 Jan; 39(1):38-43.
Score: 0.021
-
Schwartz AV, Margolis KL, Sellmeyer DE, Vittinghoff E, Ambrosius WT, Bonds DE, Josse RG, Schnall AM, Simmons DL, Hue TF, Palermo L, Hamilton BP, Green JB, Atkinson HH, O'Connor PJ, Force RW, Bauer DC. Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial. Diabetes Care. 2012 Jul; 35(7):1525-31.
Score: 0.016
-
Watson NL, Sutton-Tyrrell K, Rosano C, Boudreau RM, Hardy SE, Simonsick EM, Najjar SS, Launer LJ, Yaffe K, Atkinson HH, Satterfield S, Newman AB. Arterial stiffness and cognitive decline in well-functioning older adults. J Gerontol A Biol Sci Med Sci. 2011 Dec; 66(12):1336-42.
Score: 0.015
-
Sink KM, Leng X, Williamson J, Kritchevsky SB, Yaffe K, Kuller L, Yasar S, Atkinson H, Robbins M, Psaty B, Goff DC. Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study. Arch Intern Med. 2009 Jul 13; 169(13):1195-202.
Score: 0.013
-
Cesari M, Kritchevsky SB, Atkinson HH, Penninx BW, Di Bari M, Tracy RP, Pahor M. Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers: results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study. Am Heart J. 2009 Feb; 157(2):334.e1-8.
Score: 0.012
-
Yaffe K, Lindquist K, Shlipak MG, Simonsick E, Fried L, Rosano C, Satterfield S, Atkinson H, Windham BG, Kurella-Tamura M. Cystatin C as a marker of cognitive function in elders: findings from the health ABC study. Ann Neurol. 2008 Jun; 63(6):798-802.
Score: 0.012
-
Mangani I, Cesari M, Kritchevsky SB, Maraldi C, Carter CS, Atkinson HH, Penninx BW, Marchionni N, Pahor M. Physical exercise and comorbidity. Results from the Fitness and Arthritis in Seniors Trial (FAST). Aging Clin Exp Res. 2006 Oct; 18(5):374-80.
Score: 0.010
-
Cesari M, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BW, Lenchik L, Palla SL, Ambrosius WT, Tracy RP, Pahor M. Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am J Clin Nutr. 2005 Aug; 82(2):428-34.
Score: 0.010
-
Cesari M, Penninx BW, Lauretani F, Russo CR, Carter C, Bandinelli S, Atkinson H, Onder G, Pahor M, Ferrucci L. Hemoglobin levels and skeletal muscle: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004 Mar; 59(3):249-54.
Score: 0.009
-
Onder G, Penninx BW, Landi F, Atkinson H, Cesari M, Bernabei R, Pahor M. Depression and adverse drug reactions among hospitalized older adults. Arch Intern Med. 2003 Feb 10; 163(3):301-5.
Score: 0.008